As depicted in Fig. 5, PRMT5, PRMT1, DDAH1, DDAH2, NOS2, ARG1, and ARG2 were all found to be up-regulated in the stage I/II or stage III/IV ovarian cancer tissues compared to normal tissues. This evidence concerns the gene PRMT5 and ovarian cancer.